Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENESIS MINERALS LIMITED Director's Dealing 2021

May 19, 2021

64997_rns_2021-05-19_8e935349-0568-4998-bc9d-cecf00a9912b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Genesis Minerals Limited

ABN 72 124 772 041

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Tommy McKeith
Date of last notice 16 December 2020
Date of this notice 20 May 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Thomas David McKeith Trust>, of which Mr McKeith is a trustee and
beneficiary
Date of change 19 May 2021
No. of securities held prior to change 6,183,334 Fully Paid Ordinary Shares
5,900,000 Unlisted Options:

1,500,000 exercisable @ $0.053 per option,
vested, expiring 29/11/21

1,500,000 exercisable @ $0.056 per option,
vested, expiring 29/11/22

966,666 exercisable @ $0.106 per option,
vested, expiring 10/12/22

966,667 exercisable @ $0.114 per option,
vesting on 10/12/21, expiring 10/12/23

966,667 exercisable @ $0.122 per option,
vestingon 10/12/22,expiring10/12/24
Class Fully Paid Ordinary Shares
Number acquired 150,574 Fully Paid Ordinary Shares
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$9,034.48
No. of securities held after change 6,333,908 Fully Paid Ordinary Shares
5,900,000 Unlisted Options:

1,500,000 exercisable @ $0.053 per option,
vested, expiring 29/11/21

1,500,000 exercisable @ $0.056 per option,
vested, expiring 29/11/22

966,666 exercisable @ $0.106 per option,
vested, expiring 10/12/22

966,667 exercisable @ $0.114 per option,
vesting on 10/12/21, expiring 10/12/23

966,667 exercisable @ $0.122 per option,
vesting on 10/12/22, expiring 10/12/24
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Acquisition of shares at an issue price of $0.06 per
share pursuant to the Company’s Share Purchase
Plan that closed on 12 May2021

Part 2 – Change of director’s interests in contracts (not applicable)

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during
a+closedperiod whereprior written clearance was required?
No
If so, was prior written clearance provided to allow the trade to proceed
during this period?
N/A
If prior written clearance was provided, on what date was this provided? N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Genesis Minerals Limited

ABN 72 124 772 041

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Gerry Kaczmarek
Date of last notice 16 December 2020
Date of this notice 20 May 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Salina Kaczmarek, spouse
Date of change 19 May 2021
No. of securities held prior to change 1,072,223 Fully Paid Ordinary Shares
3,750,000 Unlisted Options:

800,000 exercisable @ $0.053 per option,
vested, expiring 29/11/21

1,200,000 exercisable @ $0.056 per option,
vested, expiring 29/11/22

583,333 exercisable @ $0.106 per option,
vested, expiring 10/12/22

583,333 exercisable @ $0.114 per option,
vesting on 10/12/21, expiring 10/12/23

583,334 exercisable @ $0.122 per option,
vestingon 10/12/22,expiring10/12/24
Class Fully Paid Ordinary Shares
Number acquired 108,702 Fully Paid Ordinary Shares
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$6,522.16
No. of securities held after change 1,180,925 Fully Paid Ordinary Shares
3,750,000 Unlisted Options:

800,000 exercisable @ $0.053 per option,
vested, expiring 29/11/21

1,200,000 exercisable @ $0.056 per option,
vested, expiring 29/11/22

583,333 exercisable @ $0.106 per option,
vested, expiring 10/12/22

583,333 exercisable @ $0.114 per option,
vesting on 10/12/21, expiring 10/12/23

583,334 exercisable @ $0.122 per option,
vesting on 10/12/22, expiring 10/12/24
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Acquisition of shares at an issue price of $0.06 per
share pursuant to the Company’s Share Purchase
Plan that closed on 12 May2021

Part 2 – Change of director’s interests in contracts (not applicable)

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during
a+closedperiod whereprior written clearance was required?
No
If so, was prior written clearance provided to allow the trade to proceed
during this period?
N/A
If prior written clearance was provided, on what date was this provided? N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2